We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

205 hedge funds and large institutions have $691M invested in SANGAMO THERAPEUTICS INC in 2020 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 77 increasing their positions, 47 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 15

64% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 47

47% more call options, than puts

Call options by funds: $15.5M | Put options by funds: $10.5M

45% more capital invested

Capital invested by funds: $476M → $691M (+$215M)

8% more funds holding

Funds holding: 190 → 205 (+15)

9.43% less ownership

Funds ownership: 64.16% → 54.73% (-9.4%)

Holders
205
Holders Change
+15
Holders Change %
+7.89%
% of All Funds
4.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
77
Reduced
47
Closed
15
Calls
$15.5M
Puts
$10.5M
Net Calls
+$4.97M
Net Calls Change
+$3.77M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$15.2M
2
Two Sigma Investments
Two Sigma Investments
New York
+$10.9M
3
BlackRock
BlackRock
New York
+$8.98M
4
GPP
Great Point Partners
Connecticut
+$8.78M
5
GLA
Great Lakes Advisors
Illinois
+$7.81M

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$14.7M
2
Citadel Advisors
Citadel Advisors
Florida
-$10.6M
3
Millennium Management
Millennium Management
New York
-$9.48M
4
Marshall Wace
Marshall Wace
United Kingdom
-$8.68M
5
TCM
Tang Capital Management
California
-$4.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
GCP
151
GSA Capital Partners
United Kingdom
$92K +$94.8K +10,223 New
CC
152
Cannell & Co
New York
$91K – – –
CLOS
153
Compagnie Lombard Odier SCmA
Switzerland
$90K – – –
AIP
154
Ameritas Investment Partners
Nebraska
$88K – – –
Canada Life
155
Canada Life
Manitoba, Canada
$70K – – –
Ensign Peak Advisors
156
Ensign Peak Advisors
Utah
$60K – – –
PAG
157
Private Advisor Group
New Jersey
$56K +$57.5K +6,200 New
FDCDDQ
158
Federation des caisses Desjardins du Quebec
Quebec, Canada
$52K +$42.7K +4,600 +383%
CAPTRUST Financial Advisors
159
CAPTRUST Financial Advisors
North Carolina
$46K +$45K +4,851 New
LWCFA
160
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$45K – – –
PFGIA
161
Patriot Financial Group Insurance Agency
Massachusetts
$45K – – –
US Bancorp
162
US Bancorp
Minnesota
$45K – – –
VCM
163
Vigilant Capital Management
Maine
$45K – – –
FMT
164
First Mercantile Trust
Tennessee
$44K -$1.25K -135 -3%
KBC Group
165
KBC Group
Belgium
$42K +$21.3K +2,300 +100%
SPIA
166
Steward Partners Investment Advisory
New York
$36K -$928 -100 -2%
MAM
167
Meeder Asset Management
Ohio
$34K +$23.4K +2,527 +191%
First Manhattan
168
First Manhattan
New York
$26K – – –
TWA
169
TCI Wealth Advisors
Arizona
$25K – – –
BWP
170
Baldwin Wealth Partners
Massachusetts
$22K – – –
Bank Julius Baer & Co
171
Bank Julius Baer & Co
Switzerland
$22K – – –
CWM
172
Cranbrook Wealth Management
Michigan
$15K – – –
BFEC
173
Benjamin F. Edwards & Company
Missouri
$13K – – –
SFS
174
Sowell Financial Services
Arkansas
$13K +$4.64K +500 +50%
Nisa Investment Advisors
175
Nisa Investment Advisors
Missouri
$12K +$325 +35 +3%
5 6
7
8 9

SGMO Hedge Fund Activity: Q2 2020 in Review

205 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2020, worth a combined $691M — up 45% from $476M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new SGMO positions and 15 closed out — a net gain of 16 holders — while 77 added to existing stakes and 47 trimmed.

The largest buyer was State Street, adding an estimated $15.2M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $14.7M sold.

  • 205 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2020, up from 190 in Q1 2020.
  • Funds reported $691M of SANGAMO THERAPEUTICS INC stock for Q2 2020, up 45% quarter-over-quarter.
  • 31 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2020 and 15 closed out, a net change of +16 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q2 2020 was State Street, an estimated $15.2M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q2 2020 was EcoR1 Capital, an estimated $14.7M sold.

Based on aggregated 13F filings for Q2 2020.